IHH Healthcare - RHB Invest 2023-08-30: Still Thriving Despite Macro Challenges; Keep BUY

• IHH Healthcare’s 2Q23 core earnings were flattish y-o-y at MYR315m, bringing 1H23 numbers to 46% and 40% of our and consensus’ estimates. Weaker-than-expected results were mainly due to higher cost of operations and utilities, as well as increased spending on repairs and maintenance.
• - Read this at SGinvestors.io -

IHH's 1H23 core earnings disappointed

• IHH Healthcare (SGX:Q0F)'s 1H23 core earnings disappointed, due to the consolidation of staff costs for its newly acquired entities, Ortopedia Hospital and Kent Health Group.
• - Read this at SGinvestors.io -
• Hospital revenue across key segments posted positive y-o-y growth, with total hospital and healthcare division revenue growth of 22% and 2% q-o-q. Key drivers were mainly the Turkey and Greater China divisions.

Segmental breakdown.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2025-02-28 IHH Healthcare - Dragged By Higher Finance Cost; Keep BUY..

Previous report by RHB:
2024-12-13 IHH Healthcare - Assessing DRG Implications In Private Hospitals.

Price targets by 2 other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News